Antifouling performance of in situ synthesized chitosan-zinc oxide hydrogel film against alga M. aeruginosa.

The undesirable settlement and growth of microalgae on submerged installations is a universal problem in water environment. Soft hydrogels are promising fouling-resistant materials due to the inherent surface properties. Herein, a kind of chitosan hydrogels with increasing zinc oxide (ZnO) mineral phase content were prepared by in situ sol-gel and solvent casting method, to prevent growth of algae Microcystis. aeruginosa. Incorporation with ZnO mineral phase improved mechanical property, water absorption, and stability of the obtained chitosan-zinc oxide (CS@ZnO) hydrogel films in Zn dose-dependent manner. The highest strength and growth inhibition (63.45 ± 8.93%) were observed by CS@ZnO-1.5 hydrogel films with the concentrations of 1.5% precursor in comparison with other hydrogel films. During this process, algal cell membrane was slightly damaged (24.5 ± 1.57%) and accompanied by significantly synthesis inhibition such as chlorophyll a (55.22 ± 2.72%) and total soluble protein (42.97 ± 1.66%). To sum up, synthesis inhibition of algal cell is the main mechanism of CS@ZnO hydrogel films inhibiting algal growth, which has the potential in antibiofouling application.

Redox-Sensitive Gelatin/Silica-Aptamer Nanogels for Targeted siRNA Delivery.

RNA interference (RNAi) has potential advantages over other gene therapy approaches due to its high specificity and the ability to inhibit target gene expression. However, the stability and tissue-specific delivery of siRNA remain as the biggest obstacles for RNAi therapeutics. Here, we developed such a system by conjugating gelatin-based nanogels with the nucleolin-targeted AS1411 aptamer and deoxynucleotide-substituted siRNA together (Apt-GS/siRNA) via a disulfide linker to achieve transient docking of siRNA. These Apt-GS/siRNA nanogels demonstrated favorable release of siRNA under reducing conditions owing to disulfide cleavage. Furthermore, this smart system could electively release siRNA into the cytosol in nucleolin-positive cells (A549) by a glutathione-triggered disassembly and subsequently efficient RNAi for luciferase. Besides, disulfide-equipped Apt-GS nanogels showed good biocompatibility in vitro. Taken together, this redox-responsive, tumor-targeting smart nanogels display great potential in exploiting functionalized siRNA delivery and tumor therapy.

Passage of Magnetic Tat-Conjugated Fe3O4@SiO2 Nanoparticles Across In Vitro Blood-Brain Barrier.

Delivery of diagnostic or therapeutic agents across the blood-brain barrier (BBB) remains a major challenge of brain disease treatment. Magnetic nanoparticles are actively being developed as drug carriers due to magnetic targeting and subsequently reduced off-target effects. In this paper, we developed a magnetic SiO2@Fe3O4 nanoparticle-based carrier bound to cell-penetrating peptide Tat (SiO2@Fe3O4-Tat) and studied its fates in accessing BBB. SiO2@Fe3O4-Tat nanoparticles (NPs) exhibited suitable magnetism and good biocompatibility. NPs adding to the apical chamber of in vitro BBB model were found in the U251 glioma cells co-cultured at the bottom of the Transwell, indicating that particles passed through the barrier and taken up by glioma cells. Moreover, the synergistic effects of Tat and magnetic field could promote the efficient cellular internalization and the permeability across the barrier. Besides, functionalization with Tat peptide allowed particles to locate into the nucleus of U251 cells than the non-conjugated NPs. These results suggest that SiO2@Fe3O4-Tat NPs could penetrate the BBB through the transcytosis of brain endothelial cells and magnetically mediated dragging. Therefore, SiO2@Fe3O4-Tat NPs could be exploited as a potential drug delivery system for chemotherapy and gene therapy of brain disease.